Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer

摘要

The invention is directed to a pharmaceutical composition containing a cancer-treating effective amount of a prostaglandin compound and analogs thereof having a metabolic rate slowing group attached thereto, and a pharmaceutically acceptable carrier, and methods of employing the same for the treatment of cancer.